Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the use of chemotherapy, radiation therapy and
bevacizumab before surgery in patients with locally advanced rectal cancer (LARC).